MedPath

Progesterone Levels During Ovulation and Luteal Phase

Completed
Conditions
Infertility, Female
Interventions
Registration Number
NCT05076981
Lead Sponsor
ART Fertility Clinics LLC
Brief Summary

Natural cycles are evaluated during fertility treatments for different therapeutic options, like insemination (IUI), time intercourse (TI) or frozen-thawed embryo transfers (FET). Two possible protocols can be used for natural cycles, with or without hCG trigger. Usually, studies including natural cycles consider both options as equivalent, not considering the possible bias that the exogenous hCG (human chorionic gonadotrophin) might have. In this prospective study, Investigators aim to evaluate the differences in the hormonal profile during the ovulation when it occurs spontaneously vs triggered with a bolus of hCG.

Detailed Description

For the pure natural cycle (PNC), ovulation will be detected by a combination of ultrasound monitoring the follicular growth and serial measurement of luteinizing hormone (LH), estradiol (E2) and progesterone (P4) levels, which is recognised to be the most accurate method of correctly identifying ovulation.

For the modified natural cycle (MNC), a bolus of rhCG 6500 IU subcutaneous (sc) will be administered when 1 dominant follicle reaches 17mm or above, after excluding previous LH surge. This is the first prospective study where the differences on the hormonal profile for ovulation will be studied.

HYPOTHESIS:

H0: The hormonal profile is not different between the PNC and the MNC H1: The hormonal profile is different between the PNC and MNC

Administration of hCG is a popular method for triggering ovulation since it may avoid the need to perform IUI or FET at weekends. However, it is an intervention compared with the detection of the spontaneous LH rise. Moreover, due to the presence of hCG receptors in the human endometrium, administration of hCG might interfere with endometrial receptivity. Previous publications evaluating pregnancy rates demonstrated that the use of hCG injection during the natural cycle reduces the pregnancy rates, in FET and IUI. It remains unclear what might be the mechanism to explain the lower pregnancy rates: a possible direct effect of hCG on the hCG receptors of the endometrium or a modification of the hormonal profile after the administration of the hCG, affecting the window of implantation (WOI).

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
6
Inclusion Criteria
  • Healthy women below 40 years
  • Regular and Ovulatory cycles
Exclusion Criteria
  • Previous adnexal surgery
  • Endometriosis
  • PCOs
  • Using hormonal contraception during the previous 2 months: OCP, progesterone IUD

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Modified Natural Cyclehuman chorionic gonadotropin* Transvaginal ultrasound (TVUS) on day 2/3 of cycle + hormones FSH, LH, E2, P4 (IVF1) * TVUS day 9-10 of cycle to identify dominant follicle. * Once the dominant follicle reaches 17mm or above, a bolus of 6500 rhCG (Ovitrelle, Merck-Serono) will be administered subcutaneously. IVF1 to be performed just before the rhCG-administration. * IVF1 2h after rhCG. * IVF1 every 12h for 2 days after rhCG. * During luteal phase, IVF1 day 7 after rhCG and day 14 after rhCG.
Primary Outcome Measures
NameTimeMethod
Difference in hormone levels35 days

Small sample data will be analyzed with the use of non-parametric test like Wilcoxon test to a paired a test of difference in hormones levels of the patients represented in both cycles (PNC and MNC) (dependent samples). This test will be preferred due to non-independent interval or ratio data in addition not to meet the normality or homogeneity of variances assumptions as paired t-test.

Hormonal pattern over the days (measured for some days during cycle 1 and cycle 2) will be analyzed using trend analysis (line fit).

Secondary Outcome Measures
NameTimeMethod
Number of visits in luteal phase17 days

Number of visits will be analyzed. The differences will be analyzed across PNC and MNC with CI. Fisher's exact test.

Luteal phase length17 days

Luteal phase length will be analyzed. The differences will be analyzed across PNC and MNC with CI. Fisher's exact test.

Trial Locations

Locations (1)

ART Fertility Clinics LLC

🇦🇪

Abu Dhabi, United Arab Emirates

© Copyright 2025. All Rights Reserved by MedPath